Autopsy report · NCT05644587

Novel Induction to Buprenorphine/Naloxone

“Low enrollment numbers”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 10 months before it stopped.
• 33 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Bicycle Health

Sponsor type

Industry

Conditions

Opioid Use Disorder; Opioid Use; Opioid Abuse; Opioid Misuse; Opioid Dependence

Interventions

buprenorphine/naloxone

Participants

33

Sites

1

Countries

United States

Trials that died the same way

• Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
  “Low enrollment rate” (86% match in meaning)
• Feasibility of the Radio-Frequency Microstimulator System to Improve Arm Function Following Traumatic Brain Injury
  “low enrollment” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.